Sun Q, Cheng K, Liao X, Zhao W, et al. New generation fluoroquinolone sitafloxacin could potentially overcome the majority levofloxacin and moxifloxacin resistance in multidrug-resistant Mycobacterium tuberculosis. J Med Microbiol 2024;73.
PMID: 39028256